LRIG Logo The Laboratory Robotics Interest Group
Mid Atlantic Chapter



February 2006
Home Up Exhibitor Info

 

The Laboratory Robotics Interest Group
Mid Atlantic Chapter

February 2006 Meeting

Automated Sample Management, Storage & Retrieval
Technology Exhibition & Presentations

Date:        Thursday, February 2, 2006
Place:      Please note that the location has changed to:
                 Doubletree Hotel & Executive Meeting Center
                 200 Atrium Drive
                 Somerset, NJ 08873
                 Phone: 732-469-2600
                 www.doubletreesomerset.com
                 Ask for the special LRIG rate of $94 if you are staying over.
Itinerary:  Exhibition & Social Period -  3:00pm to 6:00pm
                 Meeting & Presentations -     6:00pm to 9:00pm
Pre-Registration: Requested, not required.  Pre-registering will allow us to more accurately gauge seating requirements and refreshment needs.  Pre-register on the web at:
https://www.lab-robotics.org/member/meetings.asp?rid=1
There will be drawings from the  web registrants for our LRIG laser pointers, Photon key ring lights and any donated prizes.

Door Prizes:
Laser Pointers --- LRIG
$25 Starbucks Card --- GenVault
Photon Keyring Lights --- LRIG
  Door prizes for the drawings gratefully accepted - a great way to get your name out!

Agenda:  This meeting is focused on current and emerging approaches in Automated Sample Management, Storage & Retrieval technologies, as well as compound stability and integrity issues. 

The most valuable assets of any pharmaceutical research organization, the rown Jewels,?are the contents of its compound library. Unfortunately, there are many ways the integrity of these assets can be compromised in their travels through the vast and sometimes disparately managed spaces between compound storage and numerous high throughput screening assay locations, both on- and off-site. Worse still, the inefficiencies of conventional storage and transit, and the associated costs, increase geometrically as the sheer number of compounds used per HTS screening assay double and redouble.
   
from "Taming The Wasteland From Compound Storage To HTS Assay" by John Morin, Ph.D. of Wyeth Pharmaceuticals in Biomedicalproducts, March 2002

Discoveries and recent advancements in this critical area will be discussed in presentations from 6:00pm to 9:00pm.  Exhibitors will display their latest technology from 3:00pm to 6:00pm. 

Food and refreshments will be available FREE OF CHARGE during the Exhibition and Social Period.

There is always a Job posting board at the social. Please encourage your recruiters to give you material to post and distribute. Openings may also be posted at:
https://www.lab-robotics.org/forum/default.asp?CAT_ID=2.

There is no fee to attend the meeting.

Presentation:   Samples in DMSO: What an end user needs to know
Christopher Lipinski, Ph.D.; Adjunct Senior Research Fellow
Pfizer Global Research and Development, Pfizer, Inc., retired

The end user of samples in DMSO is someone who uses and stores samples for a relatively short period of time. The body of existing literature suggests storing samples in dry DMSO at room temperature for no more than three months and then discarding them. DMSO and water exhibit very non-ideal behavior when mixed together. This behavior is responsible for a range of property changes when the two solvents interact. These include; the hygroscopicity of DMSO; the viscosity increase when DMSO is wet and most importantly for this discussion: the marked solubility decrease of compounds in wet DMSO. When compounds precipitate from wet DMSO about half the time they can be resolubilized by sonication. The trend in chemistry to make amorphous compounds is an advantage in that initial solubilization in DMSO is easy. The downside is that the DMSO solutions have to be kept absolutely dry and freeze thaw cycles need to be minimized. Trifluoroacetic (TFA) contamination of samples in DMSO is a serious problem. TFA as low as 10 nM is cytotoxic in 24-hour cell cultures. This is not much of a problem in the typical short incubation HTS but it could be a problem as longer time interval safety assays get pushed into discovery. When TFA contaminated samples in DMSO become wet, acid hydrolysis becomes a serious concern. Many heterocycles made by a dehydration step are perfectly stable under neutral conditions but are hydrolyzed by TFA in wet DMSO.

Presentation:   Poor Aqueous Solubility and Compound Aggregation: Detection, Differences, and impact on In-Vitro Screens
Joseph Goodwin
BD Biosciences


Poor aqueous solubility and compound aggregation are two persistent problems that interfere with both high throughput and secondary screens. Poor solubility and compound aggregation both directly impact the effective compound concentration and the accuracy of the in-vitro assay results. In addition, the formation of compound aggregates can cause false positives by interacting non-specifically with the enzyme ligand interaction. The negative effects that particle formation has on in-vitro screens will be discussed. In addition, new methods that can be used to distinguish aggregation from precipitation will be presented using the BD GentestTM Solubility Scanner, a flow cytometry instrument specifically optimized for rapid and highly sensitive detection of insoluble and aggregate particles. The primary distinction of this technology verses other light scatter methods, is the ability to generate distinct light scatter signals for each particle as it passes through the excitation beam. This unique capability enables the analysis of a wide variety of sample types (from traditional assay buffers to more complex samples containing excipients and serum).

Presentation:   Automation of compound management at Schering-Plough Research Institute (SPRI)
Marybeth Burton; Associate Director, Chemical Technologies
Schering-Plough Research Institute

Proprietary research sample collections are one of the most valuable assets for large pharmaceuticals companies. Investment in technology to store, retrieve, prepare, and analyze this key resource is critical for the support of current and future drug discovery screening efforts. This presentation describes the project undertaken by Schering-Plough Research Institute (SPRI) to automate compound management processes and highlights improvements in request processing cycle time resulting from this initiative.

Presentation:   Practical Considerations for Enlightened Compound Management
Rhett Affleck, Ph.D.; V.P. Technology
Nexus Biosystems

Beyond the choices of storage systems, container types, and compound selection, many questions remain regarding how to best achieve a compound management facility goal: delivering the proper amount of each requested compound ?at the required throughput and at a reasonable cost. Precipitation and degradation of compounds in DMSO stocks is a known problem. Should compounds be stored dry, in DMSO, or both? If in DMSO, at what concentration? Should multiple copies of each compound be aliquotted and stored? These and other decisions will ultimately influence screening results and should be considered by compound managers and screeners before processes are put in place that needlessly waste or don actually deliver a large fraction of the library.

Presentation:   Compound Management, One Size Fits All? and Other Pitfalls
Paul Gosnell; Group Leader, Compound Management
Bristol-Myers Squibb


The past ten years of compound management has been an extremely dynamic period of development and growth. During this period all of the major pharmaceutical companies and many of the larger biotechnology companies have invested heavily in their compound management capabilities. Much success has been achieved and through a partnering with technology vendors, compound management has become an inherent part of successful drug discovery. However, the past ten years has been a time of rapid change and a myriad of paths have been pursued in drug discovery, as a result many of the compound management solutions delivered have been the victims of planning, design and implementation pitfalls. This presentation will expose several common pitfalls of compound management and discuss options for avoiding the same pitfalls in future compound management endeavors.

Presentation:   GenVault: Dry-state DNA storage: Enabling Pharmacogenomics through Smart Biosample Management  
Dr. David Wellis, PhD; Senior Vice President Sales and Marketing
GenVault

The management of biosamples has become increasingly important for pharmaceutical companies and contract research organizations in light of access, traceability and cost requirements. Biosamples must be easily shipped, repeatedly accessed and conveniently distributed. Biosamples must also be stored in cost-effective, long term storage conditions that are secure and traceable. GenVault exceeds these demands with a fully integrated sample management system designed for optimizing storage and retrieval and quick accessibility of collected biological samples. The core of the platform, the GenPlate, enables long-term storage, high throughput access, standard shipment and recovery of high quality DNA all at room temperature. GenVault state of the art system is automated and offers clinical informatics to meet the needs of both small and large repositories.

Exhibitors:

bullet4titude
bulletASDI
bulletArctic White
bulletBioTech Solutions
bulletBrandel
bulletCerionx
bulletComputype
bulletCyBio
bulletDeerac Fluidics
bulletGenomic Solutions
bulletGenVault
bulletGreiner Bio-One
bulletISC BioExpress
bulletHamilton
bulletHigh Resolution Engineering
bulletHudson Control Group
bulletLabcyte
bulletLaboratory Products Sales
bulletMatrix
bulletMeCour Temperature Control
bulletNanostream
bulletNexus Biosystems
bulletReaction Biology
bulletREMP
bulletRTS Life Science
bulletSSi Robotics
bulletTekCel
bulletThe Automation Partnership
bulletThermo Electron:LAS
bulletUSA Scientific
bulletVelocity11

Exhibitor Information: https://www.lab-robotics.org/Mid_Atlantic/meetings/0602_exhibit_information.htm

Menu

Food and refreshments are free of charge to attendees - they are paid for by the exhibitors, so please be sure to visit all their exhibits!

From 3:00pm-4:00pm there will be Butler Style:
* Crab Cakes with Red Pepper Remoulade
* Vegetarian Spring Roll with Soy Dipping Sauce
* Spinach and Feta Over Lavasch
* Melon Parisienne with Prosciutto
* Iced Jumbo Shrimp

From 4:00pm-6:00pm:

FAJITA STATION
* A Uniformed Attendant to Roll to Order in Soft Flour Tortillas and Stuff to Order in Hard Corn Tortillas:
* Char Grilled Flank Steak, Lemon Pepper rubbed Chicken Breast, Saut嶪d Onions and Peppers
* Accompanied with Iceberg Chiffonade, Salsa, Cr鋗e Fraiche, Guacamole, Shredded Monterey Jack Cheese, Black Olives, and Southwestern Chili

CARVING STATION
* Honey Baked Ham with Whole Grain Mustard, Sweet and Sour Sauce

PASTA BAR
* Faralle Pasta with Saut嶪d Mushrooms, Green Peas and Pesto Sauce

DESSERT STATION
* DoubleTree Cookies

BEVERAGE STATION
* Coffee, Tea, Water, Assorted Soda
* Cash Bar

DON'T FORGET TO PRE-REGISTER TO INSURE THAT THERE IS ENOUGH FOOD AND SEATS. 
https://www.lab-robotics.org/member/meetings.asp?rid=1

Directions:
<http://www.doubletreesomerset.com/location/map.cfm>

Visit The Laboratory Robotics Interest Group homepage at https://www.lab-robotics.org


Send mail to [email protected] with questions or comments about this web site.
Copyright ?1999 Laboratory Robotics Interest Group
LRIG?is a trademark of the Laboratory Robotics Interest Group
Last modified: October 06, 2008

[LRIG Home]